AnaptysBio Inc (ANAB)
25.72
+0.10
(+0.39%)
USD |
NASDAQ |
May 08, 16:00
25.72
0.00 (0.00%)
After-Hours: 20:00
AnaptysBio Cash from Operations (TTM): -120.80M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -120.80M |
| September 30, 2023 | -97.14M |
| June 30, 2023 | -78.41M |
| March 31, 2023 | -77.15M |
| December 31, 2022 | -73.59M |
| September 30, 2022 | -88.21M |
| June 30, 2022 | -77.47M |
| March 31, 2022 | -43.73M |
| December 31, 2021 | -45.92M |
| September 30, 2021 | 16.96M |
| June 30, 2021 | 6.952M |
| March 31, 2021 | -22.25M |
| December 31, 2020 | -14.16M |
| September 30, 2020 | -67.54M |
| June 30, 2020 | -72.62M |
| March 31, 2020 | -68.53M |
| December 31, 2019 | -69.52M |
| Date | Value |
|---|---|
| September 30, 2019 | -66.00M |
| June 30, 2019 | -58.77M |
| March 31, 2019 | -52.13M |
| December 31, 2018 | -48.51M |
| September 30, 2018 | -41.03M |
| June 30, 2018 | -30.05M |
| March 31, 2018 | -23.82M |
| December 31, 2017 | -19.44M |
| September 30, 2017 | -20.20M |
| June 30, 2017 | -19.38M |
| March 31, 2017 | -15.07M |
| December 31, 2016 | -9.03M |
| September 30, 2016 | -6.112M |
| June 30, 2016 | -4.87M |
| March 31, 2016 | -9.206M |
| December 31, 2015 | -9.694M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-120.80M
Minimum
Dec 2023
16.96M
Maximum
Sep 2021
-58.84M
Average
-68.53M
Median
Mar 2020
Cash from Operations (TTM) Benchmarks
| XOMA Corp | -18.16M |
| Fate Therapeutics Inc | -132.26M |
| Ocular Therapeutix Inc | -70.23M |
| Apellis Pharmaceuticals Inc | -594.74M |
| Sutro Biopharma Inc | -111.62M |